Business Context and Reporting Period
This Form 8-K is filed by Tharimmune, Inc. (not Canton Strategic Holdings, Inc.) on June 11, 2024. The report addresses a specific corporate event regarding the company's listing status on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance status rather than financial performance.
Material Changes
The primary material change is the resolution of a listing deficiency:
- Prior Status: On June 12, 2023, the company received notice from Nasdaq of non-compliance with the minimum bid price requirement (Listing Rule 5550(a)(2)).
- Current Status: On June 11, 2024, the company received notice from Nasdaq confirming it has regained compliance with the minimum bid price requirement for continued listing.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or discussion of future risks beyond the resolution of the specific listing issue. No unusual items or contingencies are disclosed in this text.
Investor Verification Checklist
- Verify the current trading price of THAR stock to ensure it remains above the Nasdaq minimum bid price threshold.
- Confirm the company's continued compliance with other Nasdaq listing requirements (e.g., shareholder equity, market value of listed securities).
- Review the June 12, 2023, Form 8-K to understand the initial non-compliance details and any interim actions taken.